- $333.63m
- $532.00m
- $705.47m
- 77
- 68
- 97
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 749 | 593 | 677 | 687 | 705 |
Cost of Revenue | |||||
Gross Profit | 217 | 179 | 197 | 198 | 204 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 724 | 694 | 659 | 668 | 707 |
Operating Profit | 24.1 | -101 | 18.2 | 19.8 | -1.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 10.4 | -114 | 7.29 | 9.29 | -18.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.08 | -99.5 | 3.89 | 6.57 | -17.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 6.06 | -99.5 | 3.86 | 6.5 | -17.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.06 | -99.5 | 3.86 | 6.5 | -17.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.261 | -0.989 | 0.201 | 0.214 | 0.006 |